Literature DB >> 8703043

C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration.

C Trautwein1, T Rakemann, A Pietrangelo, J Plümpe, G Montosi, M P Manns.   

Abstract

Expression of the albumin gene in the liver is controlled by several liver-enriched transcription factors. However, the mechanisms which contribute to its regulation during pathophysiological states, such as liver regeneration, are still little understood. In the present study we found that during liver regeneration down-regulation of albumin mRNA expression is transcriptionally controlled through a minimal element (nucleotide -170 to +22) of the albumin promoter and is observed mainly during the G1 phase of the cell cycle, while high levels of albumin expression are preserved at later time points. Decreased albumin mRNA levels correlate with a dramatic increase in nuclear expression of C/EBP-beta/LAP, a protein known to bind to the D site of the albumin promoter and also to be involved in cell cycle control. In contrast, nuclear expression of other factors such as HNF-1 or C/EBP-alpha, which also have been shown to transcriptionally control albumin expression, is either unchanged or slightly decreased. We show that pre- and post-translational mechanisms are involved in the higher nuclear expression of C/EBP-beta/LAP as early as 1 h after hepatectomy, which also leads to its increased binding toward the D site of the albumin promoter. Finally, in vitro transcription assays with liver nuclear extracts and recombinant C/EBP-beta/LAP demonstrate that C/EBP-beta/LAP can directly down-regulate transcription mediated by the minimal element of the albumin promoter. Additionally the inhibitory role of C/EBP-beta/LAP on the albumin minimal promoter could be confirmed by transfection experiments in hepatoma cells. These results indicate that C/EBP-beta/LAP, while enhancing transcription of cell cycle-related genes and controlling G1/S phase checkpoint, down-regulates a major liver function, i.e. albumin synthesis, to prepare the hepatocyte for entry into the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703043     DOI: 10.1074/jbc.271.36.22262

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  What keeps hepatocytes on the straight and narrow? Maintaining differentiated function in the liver.

Authors:  C Selden; M Khalil; H J Hodgson
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  [Intensive insulin therapy in sepsis. Improvement of survival chances?].

Authors:  M G Jeschke
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

3.  CREB controls LAP/C/EBP beta transcription.

Authors:  M Niehof; M P Manns; C Trautwein
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Concanavalin A-induced liver injury triggers hepatocyte proliferation.

Authors:  C Trautwein; T Rakemann; N P Malek; J Plümpe; G Tiegs; M P Manns
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

5.  Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.

Authors:  Bowen Liu; Aaron W Bell; Shirish Paranjpe; William C Bowen; Jaspal S Khillan; Jian-Hua Luo; Wendy M Mars; George K Michalopoulos
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

6.  The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.

Authors:  C T Bock; N P Malek; H L Tillmann; M P Manns; C Trautwein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Overexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein.

Authors:  T Bauknecht; Y Shi
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP.

Authors:  Takahiro Masaki; Tomokazu Matsuura; Kiyoshi Ohkawa; Tatsuo Miyamura; Isao Okazaki; Tetsu Watanabe; Tetsuro Suzuki
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

9.  Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma.

Authors:  Dagmar Klein; Thomas Schubert; Raymund E Horch; Karl-Walter Jauch; Marc G Jeschke
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells.

Authors:  J W Kim; Y H Ahn
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.